Live Breaking News & Updates on Survival Analyses|Page 2

Stay updated with breaking news from Survival analyses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BeiGene Receives European Commission Approval for BRUKINSA (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma

BRUKINSA is the first and only Bruton's Tyrosine Kinase (BTK) inhibitor for marginal zone lymphoma approved in the European Union BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology ....

United States , United Kingdom , Great Britain , Mehrdad Mobasher , Kevin Mannix , Maryline Iva , Luigi Zinzani , Leukemia Lymphoma Society , European Commission , Exchange Commission , European Union , European Medicines Agency , Bristol Myers Squibb , University Of Bologna , United Kingdom Haematological Malignancy Research Network , Committee For Medicinal Products Human Use , Institute Of Haematology Ser , Tyrosine Kinase , Chief Medical Officer , Medicinal Products , Human Use , Independent Review Committee , Pier Luigi Zinzani , Full Professor , Senior Vice President , Marginal Zone Lymphoma ,